These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
275 related articles for article (PubMed ID: 33940233)
1. Ponesimod modulates the Th1/Th17/Treg cell balance and ameliorates disease in experimental autoimmune encephalomyelitis. Hou H; Sun Y; Miao J; Gao M; Guo L; Song X J Neuroimmunol; 2021 Jul; 356():577583. PubMed ID: 33940233 [TBL] [Abstract][Full Text] [Related]
2. A novel human truncated IL12rβ1-Fc fusion protein ameliorates experimental autoimmune encephalomyelitis via specific binding of p40 to inhibit Th1 and Th17 cell differentiation. Guo W; Wang C; Wang X; Luo C; Yu D; Wang Y; Chen Y; Lei W; Gao X; Yao W Oncotarget; 2015 Oct; 6(30):28539-55. PubMed ID: 26384304 [TBL] [Abstract][Full Text] [Related]
3. Simvastatin ameliorates experimental autoimmune encephalomyelitis by inhibiting Th1/Th17 response and cellular infiltration. de Oliveira DM; de Oliveira EM; Ferrari Mde F; Semedo P; Hiyane MI; Cenedeze MA; Pacheco-Silva A; Câmara NO; Peron JP Inflammopharmacology; 2015 Dec; 23(6):343-54. PubMed ID: 26559850 [TBL] [Abstract][Full Text] [Related]
4. S3I-201, a selective stat3 inhibitor, ameliorates clinical symptoms in a mouse model of experimental autoimmune encephalomyelitis through the regulation of multiple intracellular signalling in Th1, Th17, and treg cells. Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Al-Mazroua HA; Alomar HA; Al-Hamamah MA; Attia SM Mult Scler Relat Disord; 2023 May; 73():104658. PubMed ID: 36989705 [TBL] [Abstract][Full Text] [Related]
5. Korean Red Ginseng and Ginsenoside-Rb1/-Rg1 Alleviate Experimental Autoimmune Encephalomyelitis by Suppressing Th1 and Th17 Cells and Upregulating Regulatory T Cells. Lee MJ; Jang M; Choi J; Chang BS; Kim DY; Kim SH; Kwak YS; Oh S; Lee JH; Chang BJ; Nah SY; Cho IH Mol Neurobiol; 2016 Apr; 53(3):1977-2002. PubMed ID: 25846819 [TBL] [Abstract][Full Text] [Related]
6. Protective effects of catalpol and rhein in murine experimental autoimmune encephalomyelitis via regulation of T helper (Th) 1, Th2, Th17, and regulatory T cell responses. Wei M; Yang T; Li Q; Zhou D; Du Z; Fan Y J Tradit Chin Med; 2019 Dec; 39(6):809-817. PubMed ID: 32186151 [TBL] [Abstract][Full Text] [Related]
7. Naringenin Modifies the Development of Lineage-Specific Effector CD4 Wang J; Niu X; Wu C; Wu D Front Immunol; 2018; 9():2267. PubMed ID: 30327657 [TBL] [Abstract][Full Text] [Related]
8. IFN-β regulates Th17 differentiation partly through the inhibition of osteopontin in experimental autoimmune encephalomyelitis. Zhao Q; Cheng W; Xi Y; Cao Z; Xu Y; Wu T; Li C; Niu X; Chen G Mol Immunol; 2018 Jan; 93():20-30. PubMed ID: 29127843 [TBL] [Abstract][Full Text] [Related]
9. SH479, a Betulinic Acid Derivative, Ameliorates Experimental Autoimmune Encephalomyelitis by Regulating the T Helper 17/Regulatory T Cell Balance. Li J; Jing J; Bai Y; Li Z; Xing R; Tan B; Ma X; Qiu WW; Du C; Du B; Yang F; Tang J; Siwko S; Liu M; Chen H; Luo J Mol Pharmacol; 2017 May; 91(5):464-474. PubMed ID: 28213589 [TBL] [Abstract][Full Text] [Related]
11. Simvastatin alleviates experimental autoimmune encephalomyelitis through regulating the balance of Th17 and Treg in mice. Xu D; Wang M; Wang L Allergol Immunopathol (Madr); 2024; 52(5):36-43. PubMed ID: 39278849 [TBL] [Abstract][Full Text] [Related]
12. Adipose-derived mesenchymal stem cells ameliorates experimental autoimmune encephalomyelitis via modulation of Th1/Th17 and expansion of Th2/Treg responses. Zargarani S; Tavaf MJ; Soltanmohammadi A; Yazdanpanah E; Baharlou R; Yousefi B; Sadighimoghaddam B; Esmaeili SA; Haghmorad D Cell Biol Int; 2024 Aug; 48(8):1124-1137. PubMed ID: 38741520 [TBL] [Abstract][Full Text] [Related]
13. BJ-1108, a 6-Amino-2,4,5-trimethylpyridin-3-ol analogue, regulates differentiation of Th1 and Th17 cells to ameliorate experimental autoimmune encephalomyelitis. Kang Y; Timilshina M; Nam TG; Jeong BS; Chang JH Biol Res; 2017 Feb; 50(1):8. PubMed ID: 28241881 [TBL] [Abstract][Full Text] [Related]
14. Amlexanox attenuates experimental autoimmune encephalomyelitis by inhibiting dendritic cell maturation and reprogramming effector and regulatory T cell responses. Quan MY; Song XJ; Liu HJ; Deng XH; Hou HQ; Chen LP; Ma TZ; Han X; He XX; Jia Z; Guo L J Neuroinflammation; 2019 Mar; 16(1):52. PubMed ID: 30823934 [TBL] [Abstract][Full Text] [Related]
15. Arctigenin Suppress Th17 Cells and Ameliorates Experimental Autoimmune Encephalomyelitis Through AMPK and PPAR-γ/ROR-γt Signaling. Li W; Zhang Z; Zhang K; Xue Z; Li Y; Zhang Z; Zhang L; Gu C; Zhang Q; Hao J; Da Y; Yao Z; Kong Y; Zhang R Mol Neurobiol; 2016 Oct; 53(8):5356-66. PubMed ID: 26440666 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of Interferon Regulatory Factor 4 Suppresses Th1 and Th17 Cell Differentiation and Ameliorates Experimental Autoimmune Encephalomyelitis. Yang C; He D; Yin C; Tan J Scand J Immunol; 2015 Oct; 82(4):345-51. PubMed ID: 26110284 [TBL] [Abstract][Full Text] [Related]
17. 4-Ethylguaiacol modulates neuroinflammation and Th1/Th17 differentiation to ameliorate disease severity in experimental autoimmune encephalomyelitis. Weng WT; Kuo PC; Brown DA; Scofield BA; Furnas D; Paraiso HC; Wang PY; Yu IC; Yen JH J Neuroinflammation; 2021 May; 18(1):110. PubMed ID: 33975618 [TBL] [Abstract][Full Text] [Related]
18. IDO upregulates regulatory T cells via tryptophan catabolite and suppresses encephalitogenic T cell responses in experimental autoimmune encephalomyelitis. Yan Y; Zhang GX; Gran B; Fallarino F; Yu S; Li H; Cullimore ML; Rostami A; Xu H J Immunol; 2010 Nov; 185(10):5953-61. PubMed ID: 20944000 [TBL] [Abstract][Full Text] [Related]
19. Dehydrodiconiferyl alcohol (DHCA) modulates the differentiation of Th17 and Th1 cells and suppresses experimental autoimmune encephalomyelitis. Lee J; Choi J; Lee W; Ko K; Kim S Mol Immunol; 2015 Dec; 68(2 Pt B):434-44. PubMed ID: 26477735 [TBL] [Abstract][Full Text] [Related]
20. Bifidobacterium animalis in combination with human origin of Lactobacillus plantarum ameliorate neuroinflammation in experimental model of multiple sclerosis by altering CD4+ T cell subset balance. Salehipour Z; Haghmorad D; Sankian M; Rastin M; Nosratabadi R; Soltan Dallal MM; Tabasi N; Khazaee M; Nasiraii LR; Mahmoudi M Biomed Pharmacother; 2017 Nov; 95():1535-1548. PubMed ID: 28946394 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]